Log In
BCIQ
Print this Print this
 

MicroDose DPI delivered atropine (MDT-010)

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionAtropine sulfate delivered with microdose dry powder inhaler (DPI)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPoisoning
Indication DetailsTreat the symptoms of mild to moderate organophosphorus poisoning after adequate amounts of injectable atropine have been administered
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today